-
1
-
-
0032553342
-
Necrotising hepatitis after taking herbal remedies
-
in German
-
Strahl S, Ehret V, Dahm HH, Maier KP. Necrotising hepatitis after taking herbal remedies. Dtsch Med Wschr 1998; 123: 1410-4. (in German).
-
(1998)
Dtsch Med Wschr
, vol.123
, pp. 1410-4
-
-
Strahl, S.1
Ehret, V.2
Dahm, H.H.3
Maier, K.P.4
-
2
-
-
78349263622
-
The essential guide to herbal safety
-
a risk-benefit assessment. In: Mills M, Bone K, eds. St Louis, MO): Elsevier Churchill Livingstone
-
Schmidt M, Morgan M, Bone K, McMillan J. Kava: a risk-benefit assessment. In: Mills M, Bone K, eds. The essential guide to herbal safety. St Louis, MO): Elsevier Churchill Livingstone, 2005; 155-221.
-
(2005)
Kava
, pp. 155-221
-
-
Schmidt, M.1
Morgan, M.2
Bone, K.3
McMillan, J.4
-
5
-
-
78349299982
-
-
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany). Rejection of Drug Risks, Step II. As related to: Kava-Kava (Piper methysticum)-containing, and kavain-containing drugs, including homeopathic preparations with a final concentration up to, and including D4. 14 June 2002. Available at, accessed 18 May 2010).
-
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany). Rejection of Drug Risks, Step II. As related to: Kava-Kava (Piper methysticum)-containing, and kavain-containing drugs, including homeopathic preparations with a final concentration up to, and including D4. 14 June 2002. Available at (accessed 18 May 2010).
-
-
-
-
7
-
-
67349168679
-
Kava hepatotoxicity
-
J Ethnopharmacol
-
Teschke R, Genthner A, Wolff A. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures. J Ethnopharmacol 2009; 123: 378-84.
-
(2009)
comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures
, vol.123
, pp. 378-84
-
-
Teschke, R.1
Genthner, A.2
Wolff, A.3
-
8
-
-
0036261506
-
A systematic review of the safety of kava extract in the treatment of anxiety
-
Stevinson C, Huntley A, Ernst E. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Safety 2002; 25: 251-61.
-
(2002)
Drug Safety
, vol.25
, pp. 251-61
-
-
Stevinson, C.1
Huntley, A.2
Ernst, E.3
-
9
-
-
0038249051
-
Toxicity of kava pyrones, drug safety and precautions- a case study
-
Schulze J, Raasch W, Siegers CP. Toxicity of kava pyrones, drug safety and precautions- a case study. Phytomedicine 2003; 10 (Suppl. IV): 68-73.
-
(2003)
Phytomedicine
, vol.10
, Issue.SUPPL. 4
, pp. 68-73
-
-
Schulze, J.1
Raasch, W.2
Siegers, C.P.3
-
10
-
-
0042338744
-
Quality aspects of traditional and industrial kava-extracts
-
Loew D, Franz G. Quality aspects of traditional and industrial kava-extracts. Phytomedicine 2003; 10: 610-2.
-
(2003)
Phytomedicine
, vol.10
, pp. 610-2
-
-
Loew, D.1
Franz, G.2
-
12
-
-
0036046724
-
-
Kava extract for treating anxiety (Cochrane Review). In: Cochrane Library, Issue I, 2003 Oxford: Update Software.
-
Pittler MH, Ernst E. Kava extract for treating anxiety (Cochrane Review). In: Cochrane Library, Issue I, 2003 Oxford: Update Software.
-
-
-
Pittler, M.H.1
Ernst, E.2
-
14
-
-
34548636945
-
A re-evaluation of kava (Piper methysticum)
-
Ernst E. A re-evaluation of kava (Piper methysticum). Br J Clin Pharmacol 2007; 64: 415-7.
-
(2007)
Br J Clin Pharmacol
, vol.64
, pp. 415-7
-
-
Ernst, E.1
-
16
-
-
47849130164
-
Assessments of the risk of hepatotoxicity with kava products
-
World Health Organization., Geneva, Switzerland: WHO Document Production Services
-
World Health Organization. Assessments of the risk of hepatotoxicity with kava products. Geneva, Switzerland: WHO Document Production Services, 2007.
-
(2007)
-
-
-
17
-
-
55249125241
-
Kava hepatotoxicity
-
New Zeal Med J, Available at, accessed 18 May 2010)
-
Teschke R, Schwarzenboeck A, Akinci A. Kava hepatotoxicity: a European view. New Zeal Med J 2008; 121: 1283 Available at (accessed 18 May 2010).
-
(2008)
a European view
, vol.121
, pp. 1283
-
-
Teschke, R.1
Schwarzenboeck, A.2
Akinci, A.3
-
19
-
-
78349260262
-
Kava hepatotoxicity - a clinical review
-
Teschke R. Kava hepatotoxicity - a clinical review. Ann Hepatol 2010; 9: in press.
-
(2010)
Ann Hepatol
, vol.9
-
-
Teschke, R.1
-
20
-
-
77956692082
-
Kava hepatotoxicity
-
J Clin Pharm Ther, in press. DOI: DOI: 10.1111/j.1365-2710.2009.01131.x.
-
Teschke R, Fuchs J, Bahre R, Genthner A, Wolff A. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment. J Clin Pharm Ther 2010; 34: in press. DOI: DOI: 10.1111/j.1365-2710.2009.01131.x.
-
(2010)
comparative study of two structured quantitative methods for causality assessment
, vol.34
-
-
Teschke, R.1
Fuchs, J.2
Bahre, R.3
Genthner, A.4
Wolff, A.5
-
21
-
-
0003553395
-
Kava, the Pacific elixir
-
New Haven: Yale University Press
-
Lebot V, Merlin M, Lindstrom L. Kava, the Pacific elixir. New Haven: Yale University Press, 1997.
-
(1997)
-
-
Lebot, V.1
Merlin, M.2
Lindstrom, L.3
-
22
-
-
0026728263
-
Kava
-
J Ethnopharmacol
-
Singh YH. Kava: an overview. J Ethnopharmacol 1992; 37: 13-45.
-
(1992)
an overview
, vol.37
, pp. 13-45
-
-
Singh, Y.H.1
-
23
-
-
38849103386
-
The quality of kava consumed in the South Pacific
-
Lebot V. The quality of kava consumed in the South Pacific. Herbal Gram 2006; 71: 34-7.
-
(2006)
Herbal Gram
, vol.71
, pp. 34-7
-
-
Lebot, V.1
-
24
-
-
23044503814
-
Potential for interaction of kava and St. John's wort with drugs
-
Singh YH. Potential for interaction of kava and St. John's wort with drugs. J Ethnopharmacol 2005; 100: 108-13.
-
(2005)
J Ethnopharmacol
, vol.100
, pp. 108-13
-
-
Singh, Y.H.1
-
25
-
-
38849087754
-
Quality criteria for kava
-
Schmidt M. Quality criteria for kava. HerbalGram 2007; 73: 45-9.
-
(2007)
HerbalGram
, vol.73
, pp. 45-9
-
-
Schmidt, M.1
-
30
-
-
77949379937
-
Black cohosh and suspected hepatotoxicity - inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm
-
Menopause
-
Teschke R. Black cohosh and suspected hepatotoxicity - inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm: a critical review. Menopause 2010; 17: 426-40.
-
(2010)
a critical review
, vol.17
, pp. 426-40
-
-
Teschke, R.1
-
31
-
-
77957716014
-
-
Letter to the editor., Menopause, DOI: DOI: 10.1097/gme.0b013e3181e32349. [Epub ahead of print].
-
Teschke R. Letter to the editor. Menopause 2010. DOI: DOI: 10.1097/gme.0b013e3181e32349. [Epub ahead of print].
-
(2010)
-
-
Teschke, R.1
-
32
-
-
16644400366
-
Kava update
-
New Zeal Med J, Available at, accessed 18 May 2010).
-
Ernst E. Kava update: a European perspective. New Zeal Med J 2004; 117: 1205. Available at (accessed 18 May 2010).
-
(2004)
a European perspective
, vol.117
, pp. 1205
-
-
Ernst, E.1
-
36
-
-
33745928735
-
A meta-analysis of the association between adherence to drug therapy and mortality
-
Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J 2006; 333: 15-8.
-
(2006)
Br Med J
, vol.333
, pp. 15-8
-
-
Simpson, S.H.1
Eurich, D.T.2
Majumdar, S.R.3
-
39
-
-
0345564969
-
Liver function test abnormalities in users of aqueous kava extracts
-
Clough AR, Bailie RS, Currie B. Liver function test abnormalities in users of aqueous kava extracts. J Toxicol/Clin Toxicol 2003; 41: 821-9.
-
(2003)
J Toxicol/Clin Toxicol
, vol.41
, pp. 821-9
-
-
Clough, A.R.1
Bailie, R.S.2
Currie, B.3
-
40
-
-
0043263837
-
Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia
-
Russmann S, Barguil Y, Cabalion P, et al. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur J Gastroenterol Hepatol 2003; 15: 1033-6.
-
(2003)
Eur J Gastroenterol Hepatol
, vol.15
, pp. 1033-6
-
-
Russmann, S.1
Barguil, Y.2
Cabalion, P.3
-
41
-
-
2242461279
-
Hepatitis aguda icterica secundaria a kava
-
Bujanda L, Palacios A, Silvariño R, Sánchez A, Muñoz C. Hepatitis aguda icterica secundaria a kava. Gastroenterol Hepatol 2002; 25: 434-5.
-
(2002)
Gastroenterol Hepatol
, vol.25
, pp. 434-5
-
-
Bujanda, L.1
Palacios, A.2
Silvariño, R.3
Sánchez, A.4
Muñoz, C.5
-
43
-
-
35248816024
-
The controvertible role of kava (Piper methysticum G. Forster) an anxiolytic herb, on toxic hepatitis
-
Amorim MFD, Diniz MFFM, Araújo MST, et al. The controvertible role of kava (Piper methysticum G. Forster) an anxiolytic herb, on toxic hepatitis. Rev Bras Farmacogn 2007; 17: 448-54.
-
(2007)
Rev Bras Farmacogn
, vol.17
, pp. 448-54
-
-
Amorim, M.F.D.1
Diniz, M.F.F.M.2
Araújo, M.S.T.3
-
44
-
-
21744457082
-
Safety review of kava (Piper methysicum) by the Natural Standard Research Collaboration
-
Ulbricht C, Basch E, Boon H, et al. Safety review of kava (Piper methysicum) by the Natural Standard Research Collaboration. Exp Opin Drug Saf 2005; 4: 779-94.
-
(2005)
Exp Opin Drug Saf
, vol.4
, pp. 779-94
-
-
Ulbricht, C.1
Basch, E.2
Boon, H.3
-
45
-
-
37349091412
-
Hepatocellular toxicity of kava leaf and root extracts
-
Lüde S, Török M, Dieterle S, et al. Hepatocellular toxicity of kava leaf and root extracts. Phytomedicine 2008; 15: 120-13.
-
(2008)
Phytomedicine
, vol.15
, pp. 120-13
-
-
Lüde, S.1
Török, M.2
Dieterle, S.3
-
46
-
-
40549094283
-
Efficacy of extracting solvents to chemical compounds of kava (Piper methysticum) root
-
Xuan TD, Fukuta AA, Wie AC, et al. Efficacy of extracting solvents to chemical compounds of kava (Piper methysticum) root. J Nat Med 2008; 62: 188-94.
-
(2008)
J Nat Med
, vol.62
, pp. 188-94
-
-
Xuan, T.D.1
Fukuta, A.A.2
Wie, A.C.3
-
47
-
-
34247135372
-
Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis
-
DiSilvestro RA, Zhang W, DiSilvestro DJ. Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis. Food Chem Toxicol 2007; 45: 1293-300.
-
(2007)
Food Chem Toxicol
, vol.45
, pp. 1293-300
-
-
DiSilvestro, R.A.1
Zhang, W.2
DiSilvestro, D.J.3
-
48
-
-
0037396162
-
Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory. Letter to the Editor
-
Schmidt M. Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory. Letter to the Editor. J Altern Complement Med 2003; 9: 183-8.
-
(2003)
J Altern Complement Med
, vol.9
, pp. 183-8
-
-
Schmidt, M.1
-
49
-
-
0141839116
-
Kava lactones and kava kava controversy
-
Whitton PA, Lau A, Salisbury A, Whitehouse J, Evans CS. Kava lactones and kava kava controversy. Phytochem 2003; 64: 673-9.
-
(2003)
Phytochem
, vol.64
, pp. 673-9
-
-
Whitton, P.A.1
Lau, A.2
Salisbury, A.3
Whitehouse, J.4
Evans, C.S.5
-
50
-
-
0036183953
-
Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots
-
Wu D, Yu L, Nair MG, DeWitt DL, Ramsewak RS. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. Phytomedicine 2002; 9: 41-7.
-
(2002)
Phytomedicine
, vol.9
, pp. 41-7
-
-
Wu, D.1
Yu, L.2
Nair, M.G.3
DeWitt, D.L.4
Ramsewak, R.S.5
-
51
-
-
78349252239
-
Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro
-
Weiss J, Sauer A, Frank A, Unger M. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Drug Metab Dispos 2006; 34: 203-7.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 203-7
-
-
Weiss, J.1
Sauer, A.2
Frank, A.3
Unger, M.4
-
52
-
-
0036842023
-
Inhibition of human cytochrome P450 activities by kava extract and kavalactones
-
Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002; 30: 1153-7.
-
(2002)
Drug Metab Dispos
, vol.30
, pp. 1153-7
-
-
Mathews, J.M.1
Etheridge, A.S.2
Black, S.R.3
-
53
-
-
2342475708
-
Kava does not display metabolic toxicity in a homogeneous cellular assay
-
Zou L, Harkey MR, Henderson GL, Dike LE. Kava does not display metabolic toxicity in a homogeneous cellular assay. Planta Med 2004; 70: 289-92.
-
(2004)
Planta Med
, vol.70
, pp. 289-92
-
-
Zou, L.1
Harkey, M.R.2
Henderson, G.L.3
Dike, L.E.4
-
54
-
-
19144363905
-
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes
-
Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes. Clin Pharmacol Ther 2005; 77: 415-26.
-
(2005)
Clin Pharmacol Ther
, vol.77
, pp. 415-26
-
-
Gurley, B.J.1
Gardner, S.F.2
Hubbard, M.A.3
-
55
-
-
3242677212
-
Pharmacokinetic and pharmacodynamic drug interactions with kava (Piper methysticum Forst. f.)
-
Anke J, Ramzan I. Pharmacokinetic and pharmacodynamic drug interactions with kava (Piper methysticum Forst. f.). J Ethnopharmacol 2004; 93: 153-60.
-
(2004)
J Ethnopharmacol
, vol.93
, pp. 153-60
-
-
Anke, J.1
Ramzan, I.2
-
56
-
-
22844441147
-
Herb-drug interactions. A literature review
-
Hu Z, Yang X, Ho PCL, et al. Herb-drug interactions. A literature review. Drugs 2005; 65: 1239-82.
-
(2005)
Drugs
, vol.65
, pp. 1239-82
-
-
Hu, Z.1
Yang, X.2
Ho, P.C.L.3
-
57
-
-
58149512737
-
Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract
-
Guo L, Li Q, Xia Q, et al. Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract. Food Chem Toxicol 2009; 47: 433-42.
-
(2009)
Food Chem Toxicol
, vol.47
, pp. 433-42
-
-
Guo, L.1
Li, Q.2
Xia, Q.3
-
59
-
-
74649085160
-
Gen expression profiling in male B6C3F1 mouse livers exposed to kava identifies - Changes in drug-metabolizing genes and potential mechanism linked to kava toxicity
-
Guo L, Shi Q, Dial S, et al. Gen expression profiling in male B6C3F1 mouse livers exposed to kava identifies - Changes in drug-metabolizing genes and potential mechanism linked to kava toxicity. Food Chem Toxicol 2010; 48: 6886-696.
-
(2010)
Food Chem Toxicol
, vol.48
, pp. 6886-696
-
-
Guo, L.1
Shi, Q.2
Dial, S.3
-
60
-
-
77951613085
-
Role of ethanol in kava hepatotoxicity
-
Li XZ, Ramzan I. Role of ethanol in kava hepatotoxicity. Phytother Res 2010; 24: 475-80.
-
(2010)
Phytother Res
, vol.24
, pp. 475-80
-
-
Li, X.Z.1
Ramzan, I.2
-
62
-
-
38849086101
-
Is the alkaloid pipermethystine connected with the claimed liver toxicity of kava products?
-
Lechtenberg M, Quandt B, Schmidt M, Nahrstedt A. Is the alkaloid pipermethystine connected with the claimed liver toxicity of kava products? Pharmazie 2008; 63: 71-4.
-
(2008)
Pharmazie
, vol.63
, pp. 71-4
-
-
Lechtenberg, M.1
Quandt, B.2
Schmidt, M.3
Nahrstedt, A.4
-
63
-
-
34347232391
-
Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats
-
Lim ST, Dragull K, Tang CS, et al. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Toxicol Sci 2007; 97: 214-21.
-
(2007)
Toxicol Sci
, vol.97
, pp. 214-21
-
-
Lim, S.T.1
Dragull, K.2
Tang, C.S.3
-
64
-
-
2442710270
-
In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones
-
Nerurkar PV, Dragull K, Tang CS. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. Toxicol Sci 2004; 79: 106-11.
-
(2004)
Toxicol Sci
, vol.79
, pp. 106-11
-
-
Nerurkar, P.V.1
Dragull, K.2
Tang, C.S.3
-
65
-
-
33646500546
-
In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum)
-
Jhoo JW, Freeman JP, Heinze TM, et al. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum). J Agric Food Chem 2006; 54: 3157-62.
-
(2006)
J Agric Food Chem
, vol.54
, pp. 3157-62
-
-
Jhoo, J.W.1
Freeman, J.P.2
Heinze, T.M.3
-
67
-
-
0037650196
-
Fatal fulminant hepatic failure induced by a natural therapy containing kava
-
Gow PJ, Connelly NJ, Hill RL, Crowley P, Angus PW. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med J Aust 2003; 178: 442-4.
-
(2003)
Med J Aust
, vol.178
, pp. 442-4
-
-
Gow, P.J.1
Connelly, N.J.2
Hill, R.L.3
Crowley, P.4
Angus, P.W.5
-
69
-
-
78349234451
-
SPC Report. Pacific kava: a producer's guide. ISBN 982-203-810-0
-
Secretariat of the Pacific Community., Suva, Fiji Islands: Secretariat of the Pacific Community,
-
Secretariat of the Pacific Community. SPC Report. Pacific kava: a producer's guide. ISBN 982-203-810-0. Suva, Fiji Islands: Secretariat of the Pacific Community, 2001.
-
(2001)
-
-
-
70
-
-
78349247696
-
-
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany), 12 May 2005. Available at, accessed 18 May 2010).
-
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany), 12 May 2005. Available at (accessed 18 May 2010).
-
-
-
-
71
-
-
78349237573
-
Kava. A human health risk assessment. Technical report Series No. 30
-
Food standards Australia and New Zealand, Food standards Australia and New Zealand, Available at, accessed 18 May 2010).
-
Food standards Australia and New Zealand Kava. A human health risk assessment. Technical report Series No. 30, 2005. Food standards Australia and New Zealand Available at (accessed 18 May 2010).
-
(2005)
-
-
-
72
-
-
34248545938
-
Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii
-
Brown AC, Onopa JO, Holck P, et al. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. Clin Toxicol 2007; 45: 549-56.
-
(2007)
Clin Toxicol
, vol.45
, pp. 549-56
-
-
Brown, A.C.1
Onopa, J.O.2
Holck, P.3
-
73
-
-
78349249204
-
-
Commission E of BGA/BfArM, 1990. Monographie Piperis methystici rhizoma (Kava-Kava-Wurzelstock). Bundesanzeiger Nr. 101; dated 1 June 1990.
-
Commission E of BGA/BfArM, 1990. Monographie Piperis methystici rhizoma (Kava-Kava-Wurzelstock). Bundesanzeiger Nr. 101; dated 1 June 1990.
-
-
-
-
74
-
-
78349253610
-
-
Deutscher Arzneimittel-Codex (DAC). Kava-Kava-Wurzelstock: Piperis methystici rhizoma. Official monograph, 1998, Govi-Verlag, Eschborn (Germany).
-
Deutscher Arzneimittel-Codex (DAC). Kava-Kava-Wurzelstock: Piperis methystici rhizoma. Official monograph, 1998, Govi-Verlag, Eschborn (Germany).
-
-
-
-
75
-
-
0015494305
-
Microsomal ethanol-oxidizing system (MEOS)
-
Biochem Biophys Res Commun
-
Teschke R, Hasumura Y, Joly JG, Ishii H, Lieber CS. Microsomal ethanol-oxidizing system (MEOS): purification and properties of a rat liver system free of catalase and alcohol dehydrogenase. Biochem Biophys Res Commun 1972; 49: 1187-93.
-
(1972)
purification and properties of a rat liver system free of catalase and alcohol dehydrogenase
, vol.49
, pp. 1187-93
-
-
Teschke, R.1
Hasumura, Y.2
Joly, J.G.3
Ishii, H.4
Lieber, C.S.5
-
76
-
-
0016703095
-
Hepatic microsomal alcohol-oxidizing system
-
J Biol Chem
-
Teschke R, Hasumura Y, Lieber CS. Hepatic microsomal alcohol-oxidizing system: affinity for methanol, ethanol, propanol and butanol. J Biol Chem 1975; 250: 7397-404.
-
(1975)
affinity for methanol, ethanol, propanol and butanol
, vol.250
, pp. 7397-404
-
-
Teschke, R.1
Hasumura, Y.2
Lieber, C.S.3
-
77
-
-
0022851547
-
Hepatic microsomal ethanol-oxidizing system (MEOS)
-
Alcoholism. Clin Exp Res
-
Teschke R, Gellert J. Hepatic microsomal ethanol-oxidizing system (MEOS): metabolic aspects and clinical implications. Alcoholism. Clin Exp Res 1986; 10 (Suppl.): 20-32.
-
(1986)
metabolic aspects and clinical implications
, vol.10
, Issue.SUPPL.
, pp. 20-32
-
-
Teschke, R.1
Gellert, J.2
-
79
-
-
0024396491
-
Identification of some human urinary metabolites of the intoxicating beverage kava
-
Duffield AM, Jamieson DD, Lidgard RO, Duffield PH, Bourne DJ. Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr 1989; 475: 273-81.
-
(1989)
J Chromatogr
, vol.475
, pp. 273-81
-
-
Duffield, A.M.1
Jamieson, D.D.2
Lidgard, R.O.3
Duffield, P.H.4
Bourne, D.J.5
-
80
-
-
0037973477
-
Hepatitis induced by kava (Piper methysticum rhizoma)
-
Stickel F, Baumüller HM, Seitz K, et al. Hepatitis induced by kava (Piper methysticum rhizoma). J Hepatol 2003; 39: 62-7.
-
(2003)
J Hepatol
, vol.39
, pp. 62-7
-
-
Stickel, F.1
Baumüller, H.M.2
Seitz, K.3
-
81
-
-
0004039221
-
Hepatotoxicity
-
Philadelphia: Lippincott Williams & Wilkins
-
Zimmerman HJ. Hepatotoxicity. Philadelphia: Lippincott Williams & Wilkins, 1999.
-
(1999)
-
-
Zimmerman, H.J.1
-
82
-
-
67651005824
-
The Kava Anxiety Depression Spectrum Study (KADSS)
-
Psychopharmacology
-
Sarris J, Kavanagh DJ, Byrne G, et al. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology 2009; 205: 399-407.
-
(2009)
a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum
, vol.205
, pp. 399-407
-
-
Sarris, J.1
Kavanagh, D.J.2
Byrne, G.3
-
83
-
-
47849099259
-
Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in Vanuatu
-
Lasme P, Davrieux F, Montet D, Lebot V. Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in Vanuatu. J Agric Food Chem 2008; 56: 4976-81.
-
(2008)
J Agric Food Chem
, vol.56
, pp. 4976-81
-
-
Lasme, P.1
Davrieux, F.2
Montet, D.3
Lebot, V.4
|